{
  "ptid_time": "130_S_4415_2012-01-13",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4415/2012-01-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 10,509 mm³, 62.6% below the reference mean. With a Z-score of -1.43 (7.6th percentile), this represents mild atrophy; hippocampal volume measures 5,883 mm³, 17.3% below the reference mean. With a Z-score of -1.59 (5.6th percentile), this represents moderate atrophy; whole brain volume measures 927,602 mm³, 4.8% below the reference mean. With a Z-score of -0.61 (27.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,668 mm³, 27.4% below the reference mean. With a Z-score of -1.68 (4.7th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,512 mm³, 2.9% below the reference mean. With a Z-score of -0.27 (39.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,784 mm³, 12.4% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy. ",
  "text_data": "Age is 75.1 years. Gender is Female. Education: 13 years. MMSE: 28.0. MoCA: 26.0. Logical Memory: 7.0. Laboratory findings: . APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.74 SUVR (profound elevated); Amyloid beta: 389.00 pg/mL (moderate reduced); Total tau: 816.90 pg/mL (profound elevated); Phosphorylated tau: 92.08 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). The CSF biomarkers (elevated T-tau, P-tau, and AV45 with moderately reduced Aβ) strongly support AD pathology. Despite relatively preserved cognitive scores (MMSE 28, MoCA 26), the biomarker profile and structural changes suggest early neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: The cognitive scores are still in the normal range, but the biomarker and atrophy profile strongly suggest early AD pathology, placing this patient in the MCI stage. Progression to dementia is likely but not yet clinically evident.)*",
  "timestamp": "2025-07-26T14:43:33.483718"
}